Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,434,862 papers from all fields of science
Search
Sign In
Create Free Account
Goserelin Acetate
Known as:
Acetate, Goserelin
, D-Ser(bu(t))(6)azgly(10)-LHRH Acetate
, Goserelin Acetate [Chemical/Ingredient]
The acetate salt of a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH). Continuous, prolonged administration of goserelin…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Drug Allergy
Endometriosis
GNRHR protein, human
Goserelin 10.8 MG Drug Implant [Zoladex]
Expand
Broader (1)
Goserelin
Narrower (1)
Zoladex
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract P4-13-27: A phase Ib dose de-escalation study of combined tamoxifen and goserelin acetate with alpelisib (BYL719) or buparlisib (BKM120) in premenopausal patients with HR+/HER2– locally…
Y. Lu
,
J. Ro
,
+6 authors
Y. Park
2016
Corpus ID: 77142555
Background: Growing evidence suggests that concomitant inhibition of the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian…
Expand
2015
2015
Phase 1 safety , tolerability , and pharmacokinetic study of single ascending doses of XM 17 ( recombinant human follicle-stimulating hormone ) in downregulated healthy women
2015
Corpus ID: 261935819
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of…
Expand
2013
2013
PREPARATION AND CHARACTERIZATION OF GOSERELIN ACETATE LOADED MICROSPHERES
P. Srinivas
,
S. Mamidi
,
Sumit J. Shah
2013
Corpus ID: 138389880
The objective of the present work was to formulate and evaluate Goserelin acetate microspheres for treating prostate and breast…
Expand
2010
2010
Abstract P1-12-01: Preoperative Endocrine Therapy with Tamoxifen and Goserelin Acetate for Hormone Receptor-Positive Premenopausal Patients
D. Shimizu
,
T. Ishikawa
,
+4 authors
I. Endo
2010
Corpus ID: 74845882
Background: Clinical trials have consistently shown that the response rates of hormone receptor-positive breast cancer patients…
Expand
Review
2009
Review
2009
The use of Goserelin in the management of endometriosis : review
J. Moodley
,
S. Ramphal
2009
Corpus ID: 70728157
Zoladex (Goserelin acetate implant) contains a synthetic decapeptide analogue of luteinising hormone releasing (GnRH) agonist…
Expand
2006
2006
A Case of Type 1 Diabetes Followed by Methimazole-Induced Hypersensitivity Syndrome
N. Ozaki
,
Y. Miura
,
Y. Oiso
Diabetes Care
2006
Corpus ID: 36307648
Viruses have generally been considered to be a major environmental factor in the etiology of type 1 diabetes. Drug-induced…
Expand
2006
2006
Treatment of dysfunctional uterine bleeding in the perimenopause: The effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment – a randomized, placebo…
H. Franke
,
F. Froukje Snaaijer
,
P. Houben
,
M. J. van der Mooren
Gynecological Endocrinology
2006
Corpus ID: 25040962
Objective. To assess the effects of adding combined estradiol/norethisterone acetate therapy (CENT) to goserelin acetate…
Expand
2005
2005
Phase-II-Studie zur kombinierten Exemestan- und Goserelin-Adjuvanz-Therapie mit und ohne Tibolon bei prämenopausalen Frauen mit rezeptorpositivem und nodal-negativem Mammakarzinom: ADAGIO-Studie
K. Pollow
,
M. Schaffrath
,
+8 authors
A. Bois
2005
Corpus ID: 73014165
Fragestellung: Goserelin unterdruckt uber den Umweg der Blockierung der hypophysaren Gonadotropin-Synthese die ovarielle…
Expand
Review
2005
Review
2005
Histrelin Hydrogel Implant--Valera: Histrelin implant, LHRH-Hydrogel implant, RL 0903, SPD 424.
Drugs in R&D
2005
Corpus ID: 13016559
Valera Pharmaceuticals, formerly Hydro Med Sciences, is developing a once-yearly Histrelin Hydrogel Implant [Histrelin implant…
Expand
1991
1991
Hormonelle Folgetherapien nach Goserelin (Zoladex®) beim metastasierten Mammakarzinom prämenopausaler Patientinnen
G. Minckwitz
,
M. Kaufmann
,
D. Möhrle
,
H. Schmid
,
G. Bastert
Archives of Gynecology and Obstetrics
1991
Corpus ID: 45482666
Der GnRH-Agonist Zoladex® (Z) (3,6 mg Goserelin; slow releasing depot-Praparat, s.c. alle 4 Wochen appliziert) hat sich als…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required